GCB Mr. Lin, you enjoyed a decades-long career in the ICT industry before making the transition to healthcare. What can you tell our readers about the evolution of General Biologics Corp. under your leadership? GBC was established in 1984. Government shareholders held 70 percent ownership, with the remaining 30 percent distributed…
Gene Health The President of Gene Health, a company specialized in genomics testing, talks about the current market situation for genomic testing, and building the business in the Chinese market, as well as the company’ relationship with Vita Genomics. What interested you in the genomics business, and what are your strategies for…
Biotechnology The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as well as the strategic shift towards becoming a semi-virtual model company. He also considers the importance of creating global links to capital as a…
government relations A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to streamlining regulatory and approval processes, removing duplication from international partners and utilizing modern communications technology to improve transparency and efficiency. Could you provide a brief overview of…
Generics Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference pricing and cooperation in the region. How have the markets in Denmark and Sweden evolves over the past five years, since the financial crisis started and austerity…
healthcare Dr. Nafsiah Mboi, who currently serves as the Minister of Health of Indonesia, has more than 40 years of experience in national and global public health, including a full career as a civil servant in the Ministry of Health and six years as Secretary of Indonesia’s National AIDS Commission. She…
Phytohealth Phytohealth is a trailbalzer in the Taiwanese biotech industry: the first publically-listed biopharma company in the country, and the first company to receive NDA approval for a Botanical New Drug. What was the vision behind this business? Phytohealth was founded in 1998. Its original purpose was to develop an extract…
Country Report Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The main cause of the crisis was a drastic increase in the number of recobros (individuals asking to be reimbursed for…
IMS Health Ireland Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some time as a post-doctoral researcher for a Swedish biotech company that was contracting research services here in Ireland. I have since hung up my lab…
Clonmel Healthcare Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal was exporting medicines to third world countries. We were the first company in Ireland to become involved in generics. We…
Federal Public Service (FPS) Health With an expenditure of more than 10% of GDP on health, Belgium maintains one of the world’s leading healthcare systems. That said, could you please comment on the current state of the healthcare system and the governments’ key priorities with respect to health? Indeed, Belgium does boast a highly commendable…
Cardinal Health China We last met with you as the head of Zuellig in 2009. Obviously, a lot has changed since then; from both a sector and corporate point of view, what have been the most important changes since our last report? As you will probably hear from other people, the most significant…
See our Cookie Privacy Policy Here
